SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-05-01 10:37
Tx date 2023-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Common Shares Class A
57 - Exercise of rights

+27,778 vol
2,331,414
Filed 2023-05-01 10:36
Tx date 2022-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
2,303,636
Filed 2023-05-01 10:34
Tx date 2023-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Restricted Share Units (RSUs)
57 - Exercise of rights

-27,778 vol
0
Filed 2022-05-02 14:00
Tx date 2022-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Restricted Share Units (RSUs)
56 - Grant of rights
$15,000
+27,778 vol
$0.54 each
27,778
Filed 2022-05-02 13:02
Tx date 2022-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2022-05-02 13:01
Tx date 2022-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Restricted Share Units (RSUs)
56 - Grant of rights
$8,100
+15,000 vol
$0.54 each
15,000
Filed 2022-05-02 13:01
Tx date 2022-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Restricted Share Units (RSUs)
56 - Grant of rights
$8,100
+15,000 vol
$0.54 each
Filed 2022-05-02 13:01
Tx date 2022-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-02 13:00
Tx date 2022-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
150,000
Filed 2022-05-02 13:00
Tx date 2022-04-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-14 08:01
Tx date 2020-07-10
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption

+22,500 vol
22,500
Filed 2020-07-14 08:00
Tx date 2018-12-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-14 07:59
Tx date 2020-07-10
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Debentures (Non-Convertible) July 2020
16 - Acquisition or disposition under a prospectus exemption

+$15,000 vol
$15,000
Filed 2020-07-14 07:59
Tx date 2018-12-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Debentures (Non-Convertible) July 2020
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-02 13:34
Tx date 2020-06-30
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+100,000 vol
100,000
Filed 2020-07-02 13:33
Tx date 2018-12-27
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-02-21 10:37
Tx date 2020-02-19
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$1,020
+2,000 vol
$0.51 each
2,303,636
Filed 2020-02-21 10:36
Tx date 2020-02-19
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$4,080
+8,000 vol
$0.51 each
2,301,636
Filed 2020-02-21 10:35
Tx date 2020-02-19
$VPH
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
10 - Acquisition or disposition in the public market
$4,800
+10,000 vol
$0.48 each
2,293,636
Filed 2019-01-04
Tx date 2018-12-27
$
VALEO PHARMA INC.
Léger, Marc François
5 - Senior Officer of Issuer
Direct Ownership
Common Shares Class A
00 - Opening Balance-Initial SEDI Report
2,283,636